Clinical Trials Browser

INDUSTRY × Patients With Advanced or Metastatic Solid Tumors × Epirubicin × Clear all

NCT02867397 2016-08-15

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors